Emerging technologies are pivotal in healthcare. GSK's María Cardenal-Iradier, Jorge Pou, and Sergio Ostalé presented to the IDIS Foundation's Innovation Committee their proposals using AI to...
The pharmaceutical industry invested €175 million in basic research, marking an 11% growth from 2021. This allocation represents one in eight euros for biomedical R&D, emphasizing...
Novartis has stated that it is focused on five therapeutic areas, including cardiovascular, immunology, and neuroscience. By markets, the company has detailed that it plans to...
Thanks to this investment plan, Novartis Italia, which already achieved a turnover of €1.72 billion in 2022, €78 million of which was obtained through exports, further...
Tata Motors has spent Rs 2,100.1 crore for research and development.